
Yield10 Bioscience YTEN
Quarterly report 2024-Q2
added 08-14-2024
Yield10 Bioscience Accounts Receivables 2011-2026 | YTEN
Accounts receivable — is the amount of money owed to a company by other organizations, individuals, or the government. It arises when a company has already delivered goods, performed work, or provided services, but has not yet received payment for them.Examples of accounts receivable
- Customers have not paid invoices for delivered products
- An advance has been paid to a supplier, but goods have not yet been received
- Employees have not reported on accountable amounts
- The government must refund tax overpayments
- Outstanding loans issued
- Asset quality
Accounts receivable are part of current assets. But they are not cash — they are promises. Investors assess how realistic these promises are to be collected. The higher the share of overdue or doubtful receivables, the greater the risk of asset impairment. - Impact on cash flow
Even if a company shows a profit, the money can be "tied up" in receivables. This means profit does not turn into actual cash, and the company may face liquidity shortages. - Assessment of management efficiency
The following accounts receivable turnover ratios are commonly used:
Receivables turnover = Revenue / Average accounts receivable
(the higher — the better)
Days Sales Outstanding (DSO) = 365 / Turnover
(the fewer days — the faster customers pay)
If the DSO is constantly increasing — this is a red flag — customers are delaying payments, and money gets stuck in settlements.
Annual Accounts Receivables Yield10 Bioscience
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 164 K | 86 K | 72 K | 94 K | 54 K | 66 K | 238 K | 45 K | 997 K | 839 K | 146 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 997 K | 45 K | 255 K |
Quarterly Accounts Receivables Yield10 Bioscience
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | 37 K | 35 K | 124 K | 164 K | 24 K | 76 K | 39 K | 86 K | 86 K | 86 K | 86 K | 72 K | 72 K | 72 K | 72 K | 94 K | 94 K | 94 K | 94 K | 54 K | 54 K | 54 K | 54 K | 66 K | 66 K | 66 K | 66 K | 238 K | 238 K | 238 K | 238 K | 45 K | 45 K | 45 K | 45 K | 997 K | 997 K | 997 K | 997 K | 839 K | 839 K | 839 K | 839 K | 146 K | 146 K | 146 K | 146 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 997 K | 24 K | 235 K |
Accounts Receivables of other stocks in the Agricultural inputs industry
| Issuer | Accounts Receivables | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
CF Industries Holdings
CF
|
488 M | $ 104.23 | -0.06 % | $ 16.9 B | ||
|
Corteva
CTVA
|
6.37 B | $ 78.88 | -2.01 % | $ 53.6 B | ||
|
FMC Corporation
FMC
|
2.9 B | $ 13.48 | -6.36 % | $ 1.68 B | ||
|
China Green Agriculture
CGA
|
19.3 M | - | 0.51 % | $ 27.6 M | ||
|
American Vanguard Corporation
AVD
|
170 M | $ 4.47 | -3.04 % | $ 125 M | ||
|
Intrepid Potash
IPI
|
22.5 M | $ 34.28 | -5.21 % | $ 442 M | ||
|
Origin Agritech Limited
SEED
|
260 K | $ 1.05 | - | $ 5.9 M | ||
|
The Scotts Miracle-Gro Company
SMG
|
187 M | $ 68.22 | -3.06 % | $ 3.93 B | ||
|
Marrone Bio Innovations
MBII
|
13.2 M | - | -5.9 % | $ 180 M | ||
|
The Mosaic Company
MOS
|
1.11 B | $ 26.59 | -3.27 % | $ 8.5 B | ||
|
Arcadia Biosciences
RKDA
|
514 K | $ 1.88 | -4.34 % | $ 2.33 M | ||
|
CVR Partners, LP
UAN
|
59 M | $ 106.14 | 2.68 % | $ 1.12 B |